Le Lézard
Classified in: Health, Science and technology, Business
Subject: TNM

CentralReach Extends Billing Offering with Acquisition of Bronco Billing, Now Named CR BillMax Services


POMPANO BEACH, Fla., Dec. 18, 2018 /PRNewswire/ -- CentralReach, a leading provider of EHR and practice management solutions that enable applied behavior analysis (ABA) clinicians to produce superior outcomes for people with autism, announced the recent acquisition of Bronco Billing, a managed billing services provider. The acquisition serves to extend CentralReach's end-to-end offerings by giving customers access to billing expertise that has been proven to expedite and maximize revenue received.

"I couldn't be happier to add Bronco Billing to the CentralReach platform," said Chris Sullens, CentralReach CEO. "The company has developed proven workflows that not only help clients improve their clean claim rates but also help them uncover missed revenue from otherwise unfiled claims. By adding Bronco Billing and their expert billing services to the CentralReach portfolio, we are better positioned to offer our clients the best end-to-end practice management solution that they need to grow their business and focus on what matters most ? producing superior outcomes for their clients."

In conjunction with this acquisition, Bronco Billing will be renamed CR BillMax Services to reinforce its strategic importance to the CentralReach platform and complement the company's revenue cycle management software, which will be powered by BillMax technology. Under the new name, customers will now have access to managed billing services such as receivables collections, post payments, claims submission, denial re-submissions and more. CentralReach will also be adding a white-glove experience to help customers implement billing the right way from day one. The service includes access to proven billing workflows, personalized training workshops for internal staff and more. With the cost of caring for Americans with autism expected to rise to $461 billion by 2025, the addition of these billing services will provide CentralReach therapy providers with the tools they need to prepare for that rapid growth.

The acquisition is just one example of how CentralReach is investing heavily in its product. Most recently, the company embarked on a multi-state product roadshow to elicit customer feedback on the future of CentralReach solutions. These collaborative events enable CentralReach to share its vision, preview planned feature enhancements and identify additional pain points that the company can address for its client base. The company will continue to host product roadshows and plans to introduce a user conference in 2019 to expand opportunities to engage with its client base and feed key inputs to its product management team.

About CentralReach
CentralReach is a leading provider of EHR and practice management solutions that enables applied behavior analysis (ABA) clinicians and educators to produce superior outcomes for people with autism and related disorders. Powered by its acquisition of Chartlytics, the company is revolutionizing the ABA space with cutting-edge solutions including precision teaching, clinical data collection, scheduling, billing, and learning management. Trusted by more than 50,000 clinicians and educators, CentralReach is committed to ongoing product improvement, market-leading industry expertise, world-class client satisfaction, and support of the ABA community to propel industry practitioners into a new era of excellence. For more information, please visit www.centralreach.com or follow us on Twitter @CentralReach.

About Bronco Billing
Bronco Billing, Inc. was formed to support individuals, small practices, and large healthcare providers with obtaining reimbursement they deserve in a timely manner. The team is comprised of professionals with over 20 years of experience in behavioral health and medical billing, specializing in Applied Behavior Analysis, Occupational Therapy, Physical Therapy, and Speech Therapy claims. Bronco Billing services support claims and billing processes for clinicians so that they can focus on clinical care of their patients.

Media Contact:
Niki Franklin
617-624-3291
[email protected]

SOURCE CentralReach


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: